Save time and get answers to complex questions with AI chat
Dabrafenib btd date 2023?How many years does kadcyla's market exclusivity last?Patent tenofovir alafenamide gilead?Dabrafenib mesylate when the patent is expiring in india?Alogliptin benzoate cost?
See the DrugPatentWatch profile for reclast
Reclast (zoledronic acid) has been on the U.S. market since 2002 (FDA approval for osteoporosis). As of 2026, that’s about 24 years. Note that Zometa is a related product (also zoledronic acid) approved earlier for cancer-related indications; Reclast and Zometa are the same active drug but used for different conditions. If you want the exact approval date or want info for a specific country, I can look that up.
Other Questions About Reclast :